PMID: 2099125Nov 1, 1990Paper

The prevalence of IgG anticardiolipin antibody at the anticoagulant clinic of the Ignacio ChavezNational Institute of Cardiology. I. Unselected population

Archivos del Instituto de Cardiología de México
R Mar ChaviraP A Reyes

Abstract

The recently described antiphospholipid antibodies syndrome (APA) is recognized because recurrent abortion, thrombocytopenia and repeated arterial and/or, venous thrombosis plus the demonstration of serum antibodies reactive with anionic phospholipids. We studied 51 patients who attend the anticoagulation clinic at our Institute. In a representative sample, we search for serum IgG specific for cardiolipin using an standard assay. We did not pick up unrecognized APA cases. The low frequency of this condition could be an explanation for our negative results in non-selected cases. Besides, this study denies a relationship between the chronic use of coumarin anticoagulants and development of peculiar antibodies.

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.